Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome

  • Henriquez D
  • Roos-Hesselink J
  • Schalij M
  • et al.
9Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Valvular heart disease constitutes the majority of all causes of heart disease in pregnancy. In the presence of valvular heart disease, the necessary haemodynamic changes of pregnancy might cause heart failure, leading to severe maternal and fetal morbidity and even mortality. Treatment of valvular heart disease is indicated when patients experience a deterioration of symptoms and in case of a severe valvular lesion. Whether medical therapy or interventional therapy is the optimal treatment for both mother and child is unclear.

Cite

CITATION STYLE

APA

Henriquez, D. D., Roos-Hesselink, J. W., Schalij, M. J., Klautz, R. J., Helmerhorst, F. M., & de Groot, C. J. (2011). Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008128.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free